Davids MS, Telford C, Abhyankar S, Waweru C, et al. Matching-adjusted indirect comparisons of safety and efficacy of acalabrutinib versus other targeted therapies in patients with treatment-naive chronic lymphocytic leukemia. Leuk Lymphoma 2021 May 6:1-16. doi: 10.1080/10428194.2021.1913144.
PMID: 33955326